Evidence map›Paper›PMID 23188809›Full record

ArticleRNA (New York, N.Y.)2013

mRNAs containing the histone 3' stem-loop are degraded primarily by decapping mediated by oligouridylation of the 3' end.

Wei Su, Sergey V Slepenkov, Michael K Slevin, Shawn M Lyons, Marcin Ziemniak, Joanna Kowalska, Edward Darzynkiewicz, Jacek Jemielity, William F Marzluff, Robert E Rhoads

Abstract read
In one paragraph

Article in RNA (New York, N.Y.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Uridylation and adenylation of RNAs.Science China. Life sciences · 2015
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Wei SuDepartment of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71130-3932, USA.
Sergey V Slepenkov
Michael K Slevin
Shawn M Lyons
Marcin Ziemniak
Joanna Kowalska
Edward Darzynkiewicz
Jacek Jemielity
William F Marzluff
Robert E Rhoads

Funding

CONTROL OF HISTONE MRNA SYNTHESISR01GM029832 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DOMINSKI, ZBIGNIEW, MARZLUFF, WILLIAM F. · 1985 to 2022
$9.0M
REGULATION OF OVALBUMIN SYNTHESIS IN CHICK OVIDUCTR01GM020818 · NIGMS · UNIVERSITY OF KENTUCKY · PI RHOADS, ROBERT E. · 1985 to 2009
$3.5M
TUT ase mediated degradation of histone mRNAF32GM087059 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SLEVIN, MICHAEL KEITH · 2009 to 2010
$72k
NIGMS NIH HHS F32 GM087059NIGMS NIH HHS F32GM87059NIGMS NIH HHS R01 GM020818NIGMS NIH HHS R01 GM029832NIGMS NIH HHS R01GM20818NIGMS NIH HHS R01GM29832
6 · The paper itself

Abstract

Metazoan replication-dependent histone mRNAs are only present in S-phase, due partly to changes in their stability. These mRNAs end in a unique stem-loop (SL) that is required for both translation and cell-cycle regulation. Previous studies showed that histone mRNA degradation occurs through both 5'→3' and 3'→5' processes, but the relative contributions are not known. The 3' end of histone mRNA is oligouridylated during its degradation, although it is not known whether this is an essential step. We introduced firefly luciferase reporter mRNAs containing the histone 3' UTR SL (Luc-SL) and either a normal or hDcp2-resistant cap into S-phase HeLa cells. Both mRNAs were translated, and translation initially protected the mRNAs from degradation, but there was a lag of ∼40 min with the uncleavable cap compared to ∼8 min for the normal cap before rapid decay. Knockdown of hDcp2 resulted in a similar longer lag for Luc-SL containing a normal cap, indicating that 5'→3' decay is important in this system. Inhibition of DNA replication with hydroxyurea accelerated the degradation of Luc-SL. Knockdown of terminal uridyltransferase (TUTase) 4 but not TUTase 3 slowed the decay process, but TUTase 4 knockdown had no effect on destabilization of the mRNA by hydroxyurea. Both Luc-SL and its 5' decay intermediates were oligouridylated. Preventing oligouridylation by 3'-deoxyadenosine (cordycepin) addition to the mRNA slowed degradation, in the presence or absence of hydroxyurea, suggesting oligouridylation initiates degradation. The spectrum of oligouridylated fragments suggests the 3'→5' degradation machinery stalls during initial degradation, whereupon reuridylation occurs.

Indexed as

3' Untranslated RegionsDeoxyadenosinesDNA ReplicationGene SilencingHeLa CellsHistonesHumansHydroxyureamRNA Cleavage and Polyadenylation FactorsNucleic Acid Synthesis InhibitorsOligoribonucleotidesPolynucleotide AdenylyltransferaseProtein BiosynthesisRNA, MessengerRNA StabilityTransduction, Genetic3' Untranslated RegionscordycepinDeoxyadenosinesHistonesHydroxyureamRNA Cleavage and Polyadenylation FactorsNucleic Acid Synthesis InhibitorsOligoribonucleotidesoligo(U)Polynucleotide AdenylyltransferaseRNA, MessengerTENT2 protein, humanUracil Nucleotides

Identifiers

PMID23188809
PMCPMC3527721

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.